Current Drug Trends and Emerging Drugs of Abuse
ID: 4103WEBMany new drugs are making local and national headlines such as K2/Spice and Bath Salts. This interactive webinar will discuss the latest developments and information regarding synthetic cannabinoids, MDPV, Mephedrone, Kratom, Salvia and other designer drugs that have been emerging over the past few years. Webinar participants will be introduced to the physiology of these drugs and how they can possibly impact, mimic and exacerbate mental health disorders such as anxiety and depressive disorders. Epidemiologic trends in drug abuse in both youth and adults will be discussed as will the latest trends from the New Jersey Division of Addiction Services. Webinar participants will participate in interactive discussions and exercises in differential diagnosis of similar symptoms produced by these emerging drugs of abuse and other mental health disorders. Patterns of use, abilities for urine detection, and other legal aspect regarding these emerging drugs will be discussed. [This webinar will complete your prescription opioid social work license requirement.]
Fee: $60.00
Continuing Ed. Hours (CEH): 2.0 General, 1.0 Prescription Opioids
| | Instructor: | Glenn Duncan, LPC, LCADC, CCS, ACS
|
|---|
| Date: | Thursday, August 28, 2025 |
|---|
| Time: | 9:30 am - 12:30 pm ET |
|---|
| Location: | Live Interactive Online Webinar
|
|---|
 More Details |
Exposure and Response Prevention (ERP) for OCD
ID: 5494WEBThis two-hour webinar will provide an overview of Obsessive Compulsive Disorder (OCD) and Exposure and Ritual Prevention (ERP) therapy as a treatment method. This presentation will give attendees a firm understanding of what OCD is, what OCD is not, and how to assess OCD. Next, we will review treatment principles, how and why ERP works, and how to deliver ERP in a therapeutic setting. The presentation will also cover why client education about OCD and the involvement of a client’s family and/or social circle are so important.
Note: A follow-up to this webinar is Advanced ERP for OCD, Friday, August 15, 2025, 1:00 pm - 2:30 pm. Fee: $40.00
Continuing Ed. Hours (CEH): 2.0 Clinical
| | Instructor: | Andrew Schmidt, PhD, LCSW-R
|
|---|
| Date: | Friday, August 8, 2025 |
|---|
| Time: | 2:00 pm - 4:00 pm ET |
|---|
| Location: | Live Interactive Online Webinar
|
|---|
More Details |
Harm Reduction: From Principles to Practice
ID: 4217WEBThis interactive webinar will discuss all aspects of harm reduction. Participants will be able to identify at least 3 principles of harm reduction work. Participants will be able to define harm reduction. Participants will also be able to differentiate between a successful harm reduction approach and less successful approaches and identify at least two reasons behind unsuccessful approaches. Participants will be introduced into the diagnostic criteria of the DSM and dimensional criteria of the ASAM 3, in the lens of determining the need of admission to treatment and continued care need from a harm reduction treatment perspective. Participants will be able to identify three different medicated assisted treatments (MAT), and discussion of medicinal marijuana being added as an MAT option. [This webinar will complete your prescription opioid social work license requirement.]
Fee: $60.00
Continuing Ed. Hours (CEH): 2.0 General, 1.0 Prescription Opioids
| | Instructor: | Glenn Duncan, LPC, LCADC, CCS, ACS
|
|---|
| Date: | Tuesday, August 26, 2025 |
|---|
| Time: | 9:30 am - 12:30 pm ET |
|---|
| Location: | Live Interactive Online Webinar
|
|---|
More Details |
Not Just Benzodiazepines: Alternative Treatments of Anxiety and Depression
ID: 4199WEBThe primary goal of this webinar is to explore non-pharmaceutical treatment of depression and anxiety. The number of people looking for non-pharmaceutical interventions is increasing in both the psychiatric and addiction fields. One need look no further than the desire to decrease benzodiazepine (BZD) use. Treatments to be discussed include herbal and amino acid substances as well as vagal nerve stimulation.
Fee: $60.00
Continuing Ed. Hours (CEH): 1.0 General, 2.0 Clinical
| | Instructor: | Craig Strickland, PhD
|
|---|
| Date: | Tuesday, August 5, 2025 |
|---|
| Time: | 9:30 am - 12:30 pm ET |
|---|
| Location: | Live Interactive Online Webinar
|
|---|
More Details |
The Opioid Crisis in NJ: Current Trends and Evidence-Based Treatment Options
ID: 4969WEBThis interactive webinar will discuss the latest developments and trends regarding natural opiates, semi-synthetic opioids, and synthetic opioids. Participants will be able to identify national and local NJ trends with regards to prescribing practices and new legislation, opioid overdoses and trends with opioid use. Participants will be able to distinguish the difference between which drugs are considered naturally occurring opiates, which are considered semi-synthetic opioids and which are considered synthetic opioids. Participants will be introduced into the assessment of and treatment of Opioid Use Disorders via the DSM 5 criteria, the latest nationally recognized medicated assisted treatment and the non-medication assisted treatment approaches when working with clients. Participants will be able to identify three different medicated assisted treatments (MAT), and discussion of medicinal marijuana being added as an MAT option. Webinar participants will be introduced to a harm reduction treatment paradigm and will be able to identify at least 3 different harm reduction principles when working with clients. Finally, participants will engage in an interactive case that will develop throughout the webinar and have different objectives (e.g., assessing a proper level of care, and then incorporating a harm reduction treatment orientation with the client in regards to their MAT decision process). [This webinar will complete your prescription opioid social work license requirement]
Fee: $60.00
Continuing Ed. Hours (CEH): 2.0 General, 1.0 Prescription Opioids
| | Instructor: | Glenn Duncan, LPC, LCADC, CCS, ACS
|
|---|
| Date: | Friday, August 29, 2025 |
|---|
| Time: | 9:30 am - 12:30 pm ET |
|---|
| Location: | Live Interactive Online Webinar
|
|---|
More Details |
The Win Win: Addressing Tobacco Use for People with Behavioral Health Conditions
ID: 5381WEBTobacco use remains a leading cause of preventable death, disproportionately impacting individuals with behavioral health conditions. This interactive, solutions-focused session will explore the intersection of commercial tobacco use and behavioral health, equipping participants with the knowledge and tools to drive meaningful change.
Through engaging discussions and practical strategies, participants will critically analyze the social norms and systemic factors that sustain tobacco-related health disparities. The session will provide a comprehensive overview of FDA-approved medications for tobacco use treatment, including nicotine replacement therapies (NRT), varenicline, and bupropion, along with best practices for their effective use.
Additionally, participants will gain a deeper understanding of the stages of change in tobacco use treatment and how to implement stage-specific interventions to support individuals throughout their quit journey. By integrating these evidence-based approaches, behavioral health professionals can enhance health outcomes and improve the well-being of the communities they serve creating a true win-win scenario.
Fee: $60.00
Continuing Ed. Hours (CEH): 3.0 General
| | Instructor: | David Davis, LMSW
|
|---|
| Date: | Monday, August 4, 2025 |
|---|
| Time: | 9:30 am - 12:30 pm ET |
|---|
| Location: | Live Interactive Online Webinar
|
|---|
More Details |
